课题基金 / 基金详情

ACTIVITY/TOLERABILITY OF MOXIFLOXACIN DURING TB THERAPY

ACTIVITY/TOLERABILITY OF MOXIFLOXACIN DURING TB THERAPY
结核病治疗期间莫西沙星的活性/耐受性
批准号：
6972368
负责人：
MARC H WEINER
金额：
$0.61万
依托单位：
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
项目状态：
已结题
起止时间：
2004-08-06 至 2005-03-31
来源：
https://reporter.nih.gov/project-details/6972368
关键词：
AIDS therapyHIV infectionsantitubercular agentsclinical researchclinical trialscombination chemotherapydrug administration rate /durationdrug adverse effectdrug interactionsdrug screening /evaluationethambutolhuman subjecthuman therapy evaluationlongitudinal human studypatient oriented researchquinolinesecondary infectionvitamin B6vitamin therapy

项目成果

MARC H WEINER的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY 26PK, RIFAPENTINE PKS IN CHILDREN RECEIVING WEEKLY ISONIAZID FOR TB (HIV)
PHARMACOKINETIC ISSUES IN THE USE OF MOXIFLOXACIN FOR TREATMENT OF TUBERCULOSIS
CLINICAL TRIAL: RIFAPENTINE/ISONIAZID FOR 3 MONTHS VS 9 MO FOR LATENT TB (STUDY
CLINICAL TRIAL: EVAL OF A MOXIFLOXACIN-BASED REGIMEN FOR TB TREATMENT, STUDY 28
海外基金